Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > to launch 4 to 5 clinical study sites in USA 4Q2020

<< Previous

Bullboard Posts

Next >>

Comment by floatinketuckyon Nov 26, 2020 5:50am

174 Views

Post# 31976928

RE:RE:RE:to launch 4 to 5 clinical study sites in USA 4Q2020

Further in the midst of the covid spike the FDA found the time to review data and approve the Fast Track Designation for Theralse's Phase II NMIBC study. So the Covid consideration was not sufficent to stop a good decision by the FDA. The US hospitals likewise, may very well like to continue the good decisions. The pressure to also treat other deadly diseases besides covid are clearly gaining strength.

I think we will see US hospitals signed up in very short order.

<< Previous

Bullboard Posts

Next >>

BMO evolves InvestorLine with enhanced tools for options trading